Best AI Penny Stocks 2024 Revealed!

Introduction

The Best AI Penny Stocks give investors a higher-risk, higher-reward exposure to businesses that specialize in creating or utilizing AI technology.

A successful wager on these equities offers more rewards because they trade at very modest share prices, may be relatively unknown, and operate in specialized markets. Indeed, the financial resources and earnings of AI penny stocks are frequently constrained.

But AI is starting to spread throughout society. So, these undervalued stocks currently have great potential.

Best AI Penny Stocks

INUVInuvo$0.41
MARKRemark Holdings$1.76
AMSTAmesite$0.34
PBTSPowerbridge Technologies$0.09
POAIPredictive Oncology$0.42
LTRNLantern Pharma$5.30
OBLGOblong$2.47
  • Inuvo (INUV)

By purchasing shares in Inuvo (NYSEMKT: INUV), investors can profit from the fusion of AI and e-commerce. Platforms offered by Inuvo have the potential to change the way advertising is done in the future.

Inuvo helps advertisers target customers based on specific interests rather than identifying them based on who they are.

Given that analysts covering INUV have set a target stock price of $1, the stock, which currently trades for 41 cents, has a huge upside.

Inuvo’s IntentKey is made to move advertising away from what it refers to as “Who-based marketing,” which is based on purchases, and towards gaining insights into “who” customers are.

Consequently, IntentKey makes use of AI to offer current insights into the reasons why a consumer is or is not making a purchase.

Impressively, Amazon (NASDAQ: AMZN) is already utilizing the technology. Inuvo has had year-over-year sales growth for six consecutive quarters. Especially noteworthy is the revenue growth of 45% just in the first nine months of 2022.

  • Remark Holdings (MARK)

A technology business called Remark Holdings (NASDAQ: MARK) specializes in creating AI-powered solutions for a variety of markets, including retail, hotel, and healthcare.

The company offers virtual healthcare solutions, AI-powered retail analytics, and facial recognition technologies. Its AI platform, known as KanKan, also emphasizes AI-based vision and computing.

Remark Vision applies to forensic investigations, facial recognition, situational awareness, and deep learning video analytics.

Remark Holdings is expanding; in the third quarter, top-line revenues were $2.812 million, more than doubling year-over-year.

Remark Holdings, on the other hand, disclosed a net loss for the quarter of $8.934 million. In the same period a year ago, the business generated a net income of $72.74 million.

That is not ideal. Despite this, there are good reasons to believe in the MARK stock. The remark is motivated by the growth opportunities offered by AI, just like many other businesses in this field.

The business points out the very high 38% compound annual growth rate for the AI sector between 2020 and 2030. There is a lot to appreciate about the way Remark is positioned right now, given the strong predicted future growth in both the North American and Asian markets.

  • Amesite (AMST)

Amesite (NASDAQ: AMST) is a technology business that offers corporations, governments, and educational institutions online learning systems.

The company has created platforms with artificial intelligence that provide individualized learning opportunities. To achieve this goal, the organization works around the clock, anywhere there is an internet connection.

Based on a few reasons, the AMST stock could soar this year. In the business and educational areas, the company’s cloud-based learning platform offers a 99% learner retention rate.

Recently, the business started using GPT-3, the software that powers ChatGPT, on its platform. On April 2, the business will also launch a new platform with an improved toolbox. On February 16, Amesite and the National Association for Equal Opportunity in Higher Education started a trial program.

For AI-supported learning, that program makes use of ChatGPT. Members of the alliance are receiving the company’s V5 platform, and in early April, it will introduce its V6 platform.

  • Powerbridge Technologies (PBTS)

Software and services are offered by Powerbridge Technologies (NASDAQ: PBTS) to ease international trade and logistics. Software for customs declaration and inspection, logistics management systems, and payment options are among the company’s offerings.

It aspires to increase security and transparency while streamlining and simplifying international commercial transactions. The AI-based technologies from Powerbridge Technologies cover a variety of industries, including smart city intelligent fixtures, blockchain applications, and the Internet of Things (IoT).

If the price of PBTS stock rises in 2023, that might be a significant change. Shares of Powerbridge Technologies are now trading for 10 cents, but the one analyst who follows the stock believes it is worth $7.

Shares last traded at $5.60 in 2021, therefore there is obvious potential for big gains. When Powerbridge revealed in late 2022 that it had bought DTI Group to strengthen its position in international trade, that was the most current news surrounding this stock.

However, it seems that during 2021, other riskier industries, such as cryptocurrency mining, have more than outweighed this news.

  • Predictive Oncology (POAI)

A startup called Predictive Oncology (NASDAQ: POAI) uses AI technology in the medical industry. The business creates personalized cancer treatments using data analysis and artificial intelligence. Currently, Predictive Oncology maintains a biobank and a bank of 150,000 tumour samples. The largest privately held repository of tumour samples is that biobank. As a result, the company is screening chemicals for cancer-fighting effectiveness using AI and its PeDAL platform.

By utilizing its human tissue samples, which aren’t frequently available in the discovery phases, the company assists the biopharma industry in the early stages of drug research. 95% of all medications fail, including the majority of cancer treatments. The market value of the drug, however, could increase by 2% if pre-clinical and phase 1 drug development moved more quickly. In the most recent quarter, Predictive Oncology’s revenue rose by 45% to $455,000, but the business still makes large losses. As a result, this play currently has a significant potential upside at a relatively high risk.

  • Lantern Pharma (LTRN)

The biotech firm Lantern Pharma (NASDAQ: LTRN) is another one that makes use of AI. Lantern Pharma is focused on developing innovative cancer medicines, much like Predictive Oncology. According to the two analysts that are now following the stock, shares of LTRN stock have a potential upside of more than 200%.

Through its RADR platform, Lantern Pharma is using machine learning, AI, and advanced genomics to analyze over 25 billion data points.

The business finds genomic signatures that it thinks are tied to particular drug reactions. Then it pinpoints which substances ought to be most helpful to cancer sufferers.

By detecting genomic markers, the technology enables Lantern Pharma to reposition failed medications and discover novel molecules that may be effective in treating cancer. In the first half of this year, the business will start two of its candidate medications’ Phase 1 clinical trials in humans.

Oblong (OBLG)

A company called Oblong (NASDAQ: OBLG) offers its clients visual collaboration solutions. Mezzanine, the company’s primary product, enables real-time collaboration among users using a variety of screens and devices, making meetings more interesting and effective.

Participants in meetings can share up to 10 linked devices on a single screen thanks to technology from Oblong.

The business aims to make the computer into something considerably larger than a one-person, one-screen device. Although Oblong isn’t very invested in AI, its ability to use AI is particularly applicable to its products.

Imagine an enterprise-scale version of a more creative, immersive group chat gathering. The stock of Oblong has a lot of potential as a result, in part.

While revenues are currently declining, the corporation is still losing money. But if it can offer the immersive experience it promises, it’s worth watching all year long.

Conclusion

Today we know about Best AI Penny Stocks in this article. With very few exceptions, InvestorPlace does not publish analyses of businesses with a market cap of less than $100 million or that trade less than 100,000 shares each day. That’s because scammers and market manipulators frequently utilize these “penny stocks” as their playground. We request you to visit our previous Stock related articles. Thank You.

FAQs

What are AI penny stocks?

Big businesses dominate AI stock markets. They have all the information, cutting-edge technology, and staff needed to move things along swiftly, to start with. However, a lot of IT startups are still entering the AI space. Only seven years after OpenAI’s founding in 2015, its value is reportedly over $20 billion.

Are there ever any successful penny stocks?

Ever “go big” in the penny stock world? Although penny stocks have the potential to “go big,” these parabolic surges are frequently transient. Penny stocks commonly experience price increases of two to three times in a short period, but the 5-year charts for these businesses are typically pretty dismal.

Leave a comment